Background: In several countries, especially in Africa, the dominant method of heroin intake is smoking a joint of cannabis laced with heroin. There is no data exploring the impact of smoking heroin with cannabis on treatment outcomes.
Aim: To compare treatment outcomes between people who inject heroin and people who smoke heroin with cannabis.
Methodology: Three hundred heroin users were assessed on admission to inpatient rehabilitation and after treatment. We compared drug use, psychopathology, criminality, social functioning and general health between heroin injectors and heroin-cannabis smokers at treatment entry, and at 3 and 9 months after rehabilitation.
Results: The sample comprised 211 (70.3%) heroin-cannabis smokers and 89 (29.7%) heroin injectors. Eighty-four percent were followed up at 3 months and 75% at 9 months. At 9 months, heroin-cannabis smokers had a higher proportion of those who relapsed to heroin use compared with intravenous (IV) users (p = 0.036). The median number of heroin use episodes per day was lower for IV users than heroin-cannabis smokers at both follow-up points (p = 0.013 and 0.0019). A higher proportion of IV users was HIV positive (p = 0.002). There were no significant differences in psychopathology, general health, criminality and social functioning between IV users and heroin-cannabis smokers at all three time points.
Conclusions: Heroin users who do not inject drugs but use other routes of administration may have increased risk for relapse to heroin use after inpatient rehabilitation and should therefore have equal access to harm reduction treatment services. Advocating a transition from injecting to smoking heroin in an African context may pose unique challenges.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896288 | PMC |
| http://dx.doi.org/10.1186/s12954-019-0337-z | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prevalence of illicit drug use in young patients with sudden cardiac death.
Heart Rhythm
October 2023
Department of Cardiology, St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia; Department of Cardiology, Alfred Hospital, Prahran, Victoria, Australia; Baker Heart and Diabetes Institute, Prahran, Victoria, Australia; Department of Medicine, Dentistry and Health Sciences, Melbourne University, Parkville, Victoria, Australia. Electronic address:
Article Synopsis
- The study aimed to find out the prevalence of illicit drug use among young patients (ages 18-50) who experienced sudden cardiac death (SCD) between April 2019 and April 2021.
- Results showed that 32.5% of the 554 patients had either positive toxicology for illicit drugs or reported regular use, with cannabis being the most common drug found.
- Young SCD patients using illicit drugs tended to be predominantly male, more likely to be smokers and heavy drinkers, and often had psychiatric diagnoses, but did not show significant differences in rates of coronary disease or cardiomyopathy compared to non-users.
Smoking heroin with cannabis versus injecting heroin: unexpected impact on treatment outcomes.
Harm Reduct J
December 2019
Department of Psychiatry, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Background: In several countries, especially in Africa, the dominant method of heroin intake is smoking a joint of cannabis laced with heroin. There is no data exploring the impact of smoking heroin with cannabis on treatment outcomes.
Aim: To compare treatment outcomes between people who inject heroin and people who smoke heroin with cannabis.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!